Trizepatide 60mg

Tirzepatide is a dual GIP and GLP‑1 receptor agonist engineered to activate two key incretin pathways involved in metabolic regulation. By simultaneously engaging the glucose‑dependent insulinotropic polypeptide receptor and the glucagon‑like peptide‑1 receptor, tirzepatide produces a coordinated enhancement of insulin secretion, modulation of glucagon release, and delayed gastric emptying. Its molecular design incorporates structural modifications that extend its half‑life, enabling sustained receptor activation and stable pharmacokinetics. This dual‑agonist profile has made tirzepatide a significant molecule in metabolic research, offering a unique platform for studying multi‑hormonal incretin signaling and its effects on energy balance and nutrient handling.